Due to an illness, Peter Frampton has announced his farewell tour.
In interviews released (3/2) Saturday, the 68-year-old rocker said he had been diagnosed with a rare, incurable degenerative muscle disease called inclusion body myositis, also known as I.B.M. The disease causes muscles to progressively weaken over time but generally does not affect life expectancy.
Doctors at Johns Hopkins University hope to raise awareness and funds for research following famed guitarist Peter Frampton’s announcement that he has a rare muscular disease.
I am so thankful for everyone’s incredible support and love. I am now going to help raise awareness for IBM. Please help if you can so we can find a cure for this cruel disease. https://t.co/CSl3A8rlhN
— Peter Frampton (@peterframpton) February 25, 2019
Although the disease was first diagnosed three and a half years ago when the artist suffered a fall on stage, he initially kept his diagnosis a secret because he wanted to continue playing and touring while he still could. While the disease hasn’t affected his singing voice, it could slow his fingers and his ability to move around. “In a year’s time, I might not be able to play,” Frampton said, adding, “I want to record as much as I can in the shortest space of time.”
The farewell tour will begin June 18 in Tulsa, Oklahoma, and is scheduled to wrap up Oct. 12 in San Francisco. In what is said to be the last time, the legendary guitarist will play in iconic venues including New York’s Madison Square Garden on Sept. 13. Jason Bonham’s Led Zeppelin tribute band will open the shows.